|
1
|
DeAngelis LM: Brain tumors. N Engl J Med.
344:114–123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giese A, Rief MD, Loo MA and Berens ME:
Determinants of human astrocytoma migration. Cancer Res.
54:3897–3904. 1994.PubMed/NCBI
|
|
3
|
Giese A, Bjerkvig R, Berens ME and
Westphal M: Cost of migration: invasion of malignant gliomas and
implications for treatment. J Clin Oncol. 21:1624–1636. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jansen M, Yip S and Louis DN: Molecular
pathology in adult gliomas: diagnostic, prognostic, and predictive
markers. Lancet Neurol. 9:717–726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li LQ, Li XL, Wang L, et al: Matrine
inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7
cells. Cell Physiol Biochem. 30:631–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Z, Wang X, Wu W, et al: Effects of
matrine on proliferation and apoptosis in gallbladder carcinoma
cells (GBC-SD). Phytother Res. 26:932–937. 2012. View Article : Google Scholar
|
|
7
|
Zhang S, Zhang Y, Zhuang Y, et al: Matrine
induces apoptosis in human acute myeloid leukemia cells via the
mitochondrial pathway and Akt inactivation. PLoS One. 7:e468532012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Z, Zhang J, Wang Y, et al: Matrine, a
novel autophagy inhibitor, blocks trafficking and the proteolytic
activation of lysosomal proteases. Carcinogenesis. 34:128–138.
2013. View Article : Google Scholar
|
|
9
|
Chen K, Zhang S, Ji Y, et al: Baicalein
inhibits the invasion and metastatic capabilities of hepatocellular
carcinoma cells via down-regulation of the ERK pathway. PLoS One.
8:e729272013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang SF, Yang WE, Kuo WH, Chang HR, Chu SC
and Hsieh YS: Antimetastatic potentials of flavones on oral cancer
cell via an inhibition of matrix-degrading proteases. Arch Oral
Biol. 53:287–294. 2008. View Article : Google Scholar
|
|
11
|
Gao Q, Liu W, Cai J, et al: EphB2 promotes
cervical cancer progression by inducing epithelial-mesenchymal
transition. Hum Pathol. 45:372–381. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Demuth T, Reavie LB, Rennert JL, et al:
MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3
and p38 drive glioma invasion and progression and predict patient
survival. Mol Cancer Ther. 6:1212–1222. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang ZS, Luo P, Dai SH, Liu ZB, Zheng XR
and Chen T: Salvianolic acid B induces apoptosis in human glioma
U87 cells through p38-mediated ROS generation. Cell Mol Neurobiol.
33:921–928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mondal S, Bandyopadhyay S, Ghosh MK,
Mukhopadhyay S, Roy S and Mandal C: Natural products: promising
resources for cancer drug discovery. Anticancer Agents Med Chem.
12:49–75. 2012. View Article : Google Scholar
|
|
15
|
Chandrashekar N, Selvamani A, Subramanian
R, Pandi A and Thiruvengadam D: Baicalein inhibits pulmonary
carcinogenesis-associated inflammation and interferes with COX-2,
MMP-2 and MMP-9 expressions in-vivo. Toxicol Appl Pharmacol.
261:10–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu B, Li J, Huang D, et al: Baicalein
mediates inhibition of migration and invasiveness of skin carcinoma
through Ezrin in A431 cells. BMC Cancer. 11:5272011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang ZD, Huang C, Li ZF, et al:
Chrysanthemum indicum ethanolic extract inhibits invasion of
hepatocellular carcinoma via regulation of MMP/TIMP balance as
therapeutic target. Oncol Rep. 23:413–421. 2010.PubMed/NCBI
|
|
18
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Blaschuk OW and Devemy E: Cadherins as
novel targets for anti-cancer therapy. Eur J Pharmacol.
625:195–198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tiwari N, Gheldof A, Tatari M and
Christofori G: EMT as the ultimate survival mechanism of cancer
cells. Semin Cancer Biol. 22:194–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen HH, Zhou XL, Shi YL and Yang J: Roles
of p38 MAPK and JNK in TGF-beta1-induced human alveolar epithelial
to mesenchymal transition. Arch Med Res. 44:93–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Strippoli R, Benedicto I, Foronda M, et
al: p38 maintains E-cadherin expression by modulating
TAK1-NF-kappaB during epithelial-to-mesenchymal transition. J Cell
Sci. 123:4321–4331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei J, Li Z, Chen W, et al: AEG-1
participates in TGF-beta1-induced EMT through p38 MAPK activation.
Cell Biol Int. 37:1016–1021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grille SJ, Bellacosa A, Upson J, et al:
The protein kinase Akt induces epithelial mesenchymal transition
and promotes enhanced motility and invasiveness of squamous cell
carcinoma lines. Cancer Res. 63:2172–2178. 2003.PubMed/NCBI
|
|
27
|
Zamir E and Geiger B: Molecular complexity
and dynamics of cell-matrix adhesions. J Cell Sci. 114:3583–3590.
2001.PubMed/NCBI
|
|
28
|
Xia N, Thodeti CK, Hunt TP, et al:
Directional control of cell motility through focal adhesion
positioning and spatial control of Rac activation. FASEB J.
22:1649–1659. 2008. View Article : Google Scholar : PubMed/NCBI
|
